Xarex 10mg Tablet contains rivaroxaban, an oral anticoagulant classified as a direct Factor Xa inhibitor. It is indicated for the prevention and treatment of thromboembolic disorders, including deep vein thrombosis (DVT), pulmonary embolism (PE), and for stroke prevention in patients with non-valvular atrial fibrillation. Rivaroxaban selectively inhibits Factor Xa, a key enzyme in the coagulation cascade responsible for thrombin generation and clot formation, thereby reducing the risk of clot development without the need for routine coagulation monitoring. Xarex 10mg is typically administered once daily with food to enhance absorption and ensure optimal bioavailability. The dosage and duration of therapy depend on the clinical indication and patient-specific factors such as renal function and bleeding risk. Common adverse effects may include bleeding events, ranging from minor bruising to serious hemorrhages, and patients should be closely monitored for signs of bleeding during treatment. Caution is advised in patients with hepatic impairment, concomitant use of other anticoagulants, or those undergoing invasive procedures. Xarex should be used under strict medical supervision, with appropriate patient education regarding adherence and bleeding risk management to maximize therapeutic efficacy and safety.